New Market Research Report: Ukraine Pharmaceuticals & Healthcare Report Q1 2014
Ukraine remains a promising yet risky pharmaceutical market investment prospect. For example, in addition to persistent political issues, the country has also been unable to roll out public health insurance, which has been discussed for years. Indeed, the draft law 'On Mandatory State Social Health Insurance' was published on the Ministry of Health's website for public debate only as recently as November 2013, though it had previously been suggested that the rollout of the healthcare insurance system would start in...
View full press release